NCT04387136

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 53 (actual)
• Sponsor: University of Minnesota · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.

Detailed description

This is a level I randomized prospective outcomes study comparing two groups of patients. Within 15-30 minutes of planned wake-up Group 1 will receive 30 mcg of sublingual sufentanil and group 2 will not receive sublingual sufentanil.

Conditions

• Pain
• Pain, Acute
• Anesthesia

Interventions

Type	Name	Description
DRUG	Sublingual Sufentanil	15-30 minutes prior to planned emergence from anesthesia patients will either receive 30 mcg of sublingual sufentanil dispensed by the anesthesia provider.

Timeline

• Start date: 2020-10-14
• Primary completion: 2021-02-04
• Completion: 2021-02-04
• First posted: 2020-05-13
• Last updated: 2022-06-28
• Results posted: 2022-06-28

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study